Comment Letter
Comments on National Coverage Analysis: Transcatheter Aortic Valve Replacement and Broader CED Policy Considerations
January 14, 2026
Featured Experts: Darius Lakdawalla, PhD, Barry Liden, JD
Research
All Research Featured Research
Perspective
Benchmarking Drug Prices to Inflation Overlooks What Truly Matters: Value
December 22, 2025
Featured Experts: William Padula, PhD
Testimony
Testimony on Accelerating Medical Breakthroughs for American Patients and Their Families
December 9, 2025
Featured Experts: Darius Lakdawalla, PhD
Testimony
Testimony on Maintaining U.S. Biotech Competitiveness and Delivering Lifesaving Cures to Patients
October 29, 2025
Featured Experts: Lowell Schiller, JD
Perspective
HHS’s Chance to Save Hundreds of Boys
September 14, 2025
Featured Experts: Elizabeth Currid-Halkett, PhD
News
Schaeffer Center White Paper Outlines FDA Reforms to Boost Pharmaceutical Innovation and Expand Access
September 11, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
White Paper
A Blueprint for FDA: Recommendations to Improve Innovation and Access
September 11, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
Comment Letter
Comments to USTR on Foreign Nations Freeloading on American-Financed Innovation
June 27, 2025
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Barry Liden, JD
Perspective
Agency Overreach Leaves Patients Untreated
June 10, 2025
Featured Experts: Joseph Grogan, JD
White Paper
How Does Corporate Tax Policy Influence Innovation?
June 4, 2025
Featured Experts: Karen Mulligan, PhD, Drishti Baid, MPP, Darius Lakdawalla, PhD
Perspective
Ensuring Most-Favored Nation Drug Pricing Doesn’t Sicken Us
May 20, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Perspective
The Biotech Industry Needs to Make Its Case for Bold Change to the White House
May 7, 2025
Featured Experts: Joseph Grogan, JD
Evidence Base
Patients Win When NIH Swings for the Fences
May 1, 2025
Featured Experts: Dana Goldman, PhD, Bob Kocher, MD
Perspective
These Breakthrough Gene Therapies Cost Millions of Dollars. Is a Mortgage Model the Secret to Paying for Them?
May 1, 2025
Featured Experts: William Padula, PhD
Perspective
‘Most-Favored Nation’ Drug Pricing Has Three Significant Problems
April 14, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
News
Analysis Finds Meaningful Impact on Pharmaceutical Innovation From Reduced Revenues
February 18, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD
White Paper
The Elasticity of Pharmaceutical Innovation: How Much Does Revenue Drive New Drug Development?
February 18, 2025
Featured Experts: Karen Van Nuys, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD
Perspective
Medicare Drug Price Negotiations Need Something New: A Floor
January 22, 2025
Featured Experts: Darius Lakdawalla, PhD
Perspective
Government Needs to Do More to Ensure Obesity Drug Safety
December 16, 2024
Featured Experts: Joseph Grogan, JD